Shenzhen Lifotronic Technology Co (688389) - Net Assets

Latest as of September 2025: CN¥2.10 Billion CNY ≈ $306.77 Million USD

Based on the latest financial reports, Shenzhen Lifotronic Technology Co (688389) has net assets worth CN¥2.10 Billion CNY (≈ $306.77 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.65 Billion ≈ $387.17 Million USD) and total liabilities (CN¥549.45 Million ≈ $80.40 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 688389 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥2.10 Billion
% of Total Assets	79.23%
Annual Growth Rate	23.82%
5-Year Change	79.21%
10-Year Change	N/A
Growth Volatility	19.28

Shenzhen Lifotronic Technology Co - Net Assets Trend (2016–2024)

This chart illustrates how Shenzhen Lifotronic Technology Co's net assets have evolved over time, based on quarterly financial data. Also explore 688389 asset base for the complete picture of this company's asset base.

Annual Net Assets for Shenzhen Lifotronic Technology Co (2016–2024)

The table below shows the annual net assets of Shenzhen Lifotronic Technology Co from 2016 to 2024. For live valuation and market cap data, see 688389 stock market capitalisation.

Year	Net Assets	Change
2024-12-31	CN¥2.05 Billion ≈ $299.89 Million	+14.01%
2023-12-31	CN¥1.80 Billion ≈ $263.05 Million	+24.53%
2022-12-31	CN¥1.44 Billion ≈ $211.23 Million	+14.75%
2021-12-31	CN¥1.26 Billion ≈ $184.08 Million	+10.00%
2020-12-31	CN¥1.14 Billion ≈ $167.34 Million	+8.95%
2019-12-31	CN¥1.05 Billion ≈ $153.60 Million	+57.04%
2018-12-31	CN¥668.39 Million ≈ $97.81 Million	+13.82%
2017-12-31	CN¥587.25 Million ≈ $85.93 Million	+58.36%
2016-12-31	CN¥370.82 Million ≈ $54.26 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Shenzhen Lifotronic Technology Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1843.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥879.96 Million	42.90%
Common Stock	CN¥428.49 Million	20.89%
Other Comprehensive Income	CN¥132.27 Million	6.45%
Other Components	CN¥610.24 Million	29.75%
Total Equity	CN¥2.05 Billion	100.00%

Shenzhen Lifotronic Technology Co Competitors by Market Cap

The table below lists competitors of Shenzhen Lifotronic Technology Co ranked by their market capitalization.

Company	Market Cap
ZYLOX-TONBRDG.MED.TECH.H1 F:818	$818.27 Million
Ta Ya Electric Wire & Cable Co., Ltd. TW:1609	$818.95 Million
Niutech Environment Technology Corp SHG:688309	$819.02 Million
SGSG Science&technology Co Ltd Zhuhai SHE:300561	$819.09 Million
Lian Hwa Foods Corp TW:1231	$818.06 Million
Shengyuan Environmental Protection SHE:300867	$817.95 Million
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	$817.12 Million
Xinyaqiang Silicon Chemistry Co Ltd SHG:603155	$816.98 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shenzhen Lifotronic Technology Co's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 1,796,746,247 to 2,050,964,593, a change of 254,218,346 (14.1%).
Net income of 345,391,541 contributed positively to equity growth.
Dividend payments of 125,055,408 reduced retained earnings.
Other comprehensive income increased equity by 43,904,471.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥345.39 Million	+16.84%
Dividends Paid	CN¥125.06 Million	-6.1%
Other Comprehensive Income	CN¥43.90 Million	+2.14%
Other Changes	CN¥-10.02 Million	-0.49%
Total Change	CN¥-	14.15%

Book Value vs Market Value Analysis

This analysis compares Shenzhen Lifotronic Technology Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.71x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 1.82x to 2.71x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	CN¥7.18	CN¥13.05	x
2017-12-31	CN¥1.67	CN¥13.05	x
2018-12-31	CN¥1.73	CN¥13.05	x
2019-12-31	CN¥2.71	CN¥13.05	x
2020-12-31	CN¥2.70	CN¥13.05	x
2021-12-31	CN¥2.97	CN¥13.05	x
2022-12-31	CN¥3.44	CN¥13.05	x
2023-12-31	CN¥4.21	CN¥13.05	x
2024-12-31	CN¥4.81	CN¥13.05	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shenzhen Lifotronic Technology Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 16.84%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 30.09%
• Asset Turnover: 0.40x
• Equity Multiplier: 1.41x
Recent ROE (16.84%) is above the historical average (12.72%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2016	2.80%	5.95%	0.35x	1.34x	CN¥-26.70 Million
2017	9.61%	22.50%	0.35x	1.21x	CN¥-2.30 Million
2018	12.14%	25.09%	0.40x	1.21x	CN¥14.30 Million
2019	9.58%	23.79%	0.36x	1.12x	CN¥-4.41 Million
2020	12.59%	25.99%	0.43x	1.13x	CN¥29.65 Million
2021	15.16%	24.46%	0.53x	1.17x	CN¥64.80 Million
2022	17.47%	25.58%	0.54x	1.26x	CN¥107.50 Million
2023	18.29%	28.68%	0.49x	1.30x	CN¥148.91 Million
2024	16.84%	30.09%	0.40x	1.41x	CN¥140.30 Million

Industry Comparison

This section compares Shenzhen Lifotronic Technology Co's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $2,878,613,845
Average return on equity (ROE) among peers: 7.76%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Shenzhen Lifotronic Technology Co (688389)	CN¥2.10 Billion	2.80%	0.26x	$818.25 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$3.98 Billion	-16.09%	0.31x	$449.34 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$6.16 Billion	12.22%	0.29x	$4.30 Billion
Double Medical Technology Inc (002901)	$3.18 Billion	11.21%	0.39x	$2.63 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$592.59 Million	10.36%	0.04x	$577.41 Million
Lepu Medical Tech Beijing (300003)	$10.54 Billion	17.10%	0.73x	$3.87 Billion
INKON Life Technology Co Ltd (300143)	$81.55 Million	14.06%	1.01x	$1.23 Billion
Edan Instruments Inc (300206)	$1.18 Billion	4.69%	0.08x	$1.26 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$427.94 Million	7.90%	0.21x	$685.28 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$1.80 Billion	0.85%	0.07x	$534.16 Million
Sinocare Inc (300298)	$845.18 Million	15.24%	0.12x	$1.36 Billion

About Shenzhen Lifotronic Technology Co

SHG:688389 China Medical Devices

Market Cap

$818.25 Million

CN¥5.59 Billion CNY

Market Cap Rank

#10050 Global

#2859 in China

Share Price

CN¥13.05

Change (1 day)

+0.38%

52-Week Range

CN¥12.16 - CN¥14.74

All Time High

CN¥37.22